NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

DBPCT Effects of Omega-3 FA on Memory and Cognition in Peri- and Menopausal Women

Active Not RecruitingNA

Sponsor: St. Mary's University, Twickenham

Conditions: Menopause

Interventions: A Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Effects of Algae Omega-3 Fatty Acids on Memory and Cognition in Perimenopausal and Menopausal Women

Countries: United Kingdom

The goal of this clinical trial is to learn if daily omega-3 supplementation improves memory and cognitive function in perimenopausal and menopausal women aged 40-60 years. It will also assess whether omega-3 supplements influence menopausal symptoms, stress levels, and sleep patterns. The main questions it aims to answer are: 1. -Does omega-3 supplementation improve memory and cognitive performance? 2. \- Does omega-3 supplementation affect menopausal symptoms, stress, and perceived memory changes? 3- Are there any differences in sleep patterns during supplementation? Researchers will compare omega-3 supplements to a placebo to see if omega-3 improves memory and cognition.

Eligibility overview

Sex: FEMALE

Age: 40 Years to 60 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Be female and aged between 40-60 years
* Be experiencing perimenopause or menopause
* Access to reliable internet connection and a device to complete online questionnaires and cognitive assessments
* Be prepared to take a daily omega-3 supplement or placebo for 12 weeks
* Be prepared to complete pre- and post- intervention testing and questionnaires
* Speak English fluently to confirm they can complete cognitive tests to the best of their ability

Exclusion Criteria:

* Have diagnosed psychiatric or neurological condition (dementia, extreme depression, schizophrenia, bipolar disorder) which could affect cognitive function
* Not currently be taking omega-3 supplements or regularly consuming fatty fish (1 portion per/week)
* Be using hormone replacement therapy (HRT)
* Have severe dietary restrictions
* Have a history of stroke, cardiovascular disease or diabetes, as these conditions influence cognitive health
* Are unable to commit to both baseline and follow-up tests after the 12-week period
* Pregnant or breastfeeding

Locations (1)

London, United Kingdom